Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study

Frontiers in Pharmacology

Volumn 6, Issue JAN, 2016, Pages

  Toth, Peter P ^a,b,c   Patti, Angelo M ^d,e   Nikolic, Dragana ^d   Giglio, Rosaria V ^d,e   Castellino, Giuseppa ^d   Biancucci, Teresa ^d   Geraci, Fabiana ^d,e   David, Sabrina ^d   Montalto, Giuseppe ^b,f   Rizvi, Ali ^g   Rizzo, Manfredi ^d,e,g  

^a CGH Medical Center   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PALERMO   (Italy)

^e Euro Mediterranean Institute of Science and Technology   (Italy)

^f CNR   (Italy)

^g UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bergamot; Cardiovascular risk; Carotid IMT; Hypercholesterolemia; LDL subclasses

Indexed keywords

AURANTIIN; CHOLESTEROL; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEOERIOCITRIN; NEOHESPERIDIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BERGAMOT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CITRUS BERGAMIA; CITRUS FRUIT; CLINICAL STUDY; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GEL ELECTROPHORESIS; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84962013808     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00299     Document Type: Article

References (52)

1. Adhyaru, B. B., and Jacobson, T. A. (2015). New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendations for patient-centered management of dyslipidemia. Cardiol. Clin. 33, 181-196. doi: 10.1016/j.ccl.2015.02.001
2. Alagona, P. Jr., and Ahmad, T. A. (2015). Cardiovascular disease risk assessment and prevention: current guidelines and limitations. Med. Clin. North Am. 99, 711-731. doi: 10.1016/j.mcna.2015.02.003
3. Andersen, C., Kotowska, D., Tortzen, C. G., Kristiansen, K., Nielsen, J., and Petersen, R. K. (2014). 2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARgamma partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes. Bioorg. Med. Chem. 22, 6105-6111. doi: 10.1016/j.bmc.2014.08.037
4. Austin, M. A., Breslow, J. L., Hennekens, C. H., Buring, J. E., Willett, W. C., and Krauss, R. M. (1988). Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260, 1917-1921. doi: 10.1001/jama.1988.03410130125037
5. Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., et al. (2015a). Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opin. Drug Saf. 14, 935-955. doi: 10.1517/14740338.2015.1039980
6. Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., et al. (2015b). Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch. Med. Sci. 11, 1-23. doi: 10.5114/aoms.2015.49807
7. Benavente-Garcia, O., and Castillo, J. (2008). Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 56, 6185-6205. doi: 10.1021/jf8006568
8. Berneis, K., Rizzo, M., Berthold, H. K., Spinas, G. A., Krone, W., and Gouni-Berthold, I. (2010). Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial. Eur. Heart J. 31, 1633-1639. doi: 10.1093/eurheartj/ehq181
9. Bruckbauer, A., and Zemel, M. B. (2014). Synergistic effects of polyphenols and methylxanthines with Leucine on AMPK/Sirtuin-mediated metabolism in muscle cells and adipocytes. PLoS ONE 9:e89166. doi: 10.1371/journal.pone.0089166
10. Chang, J. J., Hsu, M. J., Huang, H. P., Chung, D. J., Chang, Y. C., and Wang, C. J. (2013). Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance. J. Agric. Food Chem. 61, 6069-6076. doi: 10.1021/jf401171k
11. Choe, S. C., Kim, H. S., Jeong, T. S., Bok, S. H., and Park, Y. B. (2001). Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 38, 947-955. doi: 10.1097/00005344-200112000-00017
12. Corrado, E., Rizzo, M., Tantillo, R., Muratori, I., Bonura, F., Vitale, G., et al. (2006). Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 37, 482-486. doi: 10.1161/01.STR.0000198813.56398.14
13. Di Donna, L., Iacopetta, D., Cappello, A. R., Gallucci, G., Martello, E., Fiorillo, M., et al. (2014). Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): "In vivo" studies. J. Funct. Foods 7, 558-568. doi: 10.1016/j.jff.2013.12.029
14. Dong, J., Zhang, X., Zhang, L., Bian, H. X., Xu, N., Bao, B., et al. (2014). Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKalpha1/SIRT1. J. Lipid Res. 55, 363-374. doi: 10.1194/jlr. M038786
15. Dugo, P., Presti, M. L., Ohman, M., Fazio, A., Dugo, G., and Mondello, L. (2005). Determination of flavonoids in citrus juices by micro-HPLC-ESI/MS. J. Sep. Sci. 28, 1149-1156. doi: 10.1002/jssc.200500053
16. Farras, M., Valls, R. M., Fernandez-Castillejo, S., Giralt, M., Sola, R., Subirana, I., et al. (2013). Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans. A randomized controlled trial. J. Nutr. Biochem. 24, 1334-1339. doi: 10.1016/j.jnutbio.2012.10.008
17. Fuhrman, B., Lavy, A., and Aviram, M. (1995). Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 61, 549-554.
18. Garcia-Rios, A., Nikolic, D., Perez-Martinez, P., Lopez-Miranda, J., Rizzo, M., and Hoogeveen, R. C. (2014). LDL and HDL subfractions, dysfunctional HDL: treatment options. Curr. Pharm. Des. 20, 6249-6255. doi: 10.2174/1381612820666140620154014
19. Gliozzi, M., Carresi, C., Musolino, V., Palma, E., Muscoli, C., Vitale, C., et al. (2014). The effect of bergamot-derived polyphenolic fraction on ldl small dense particles and non alcoholic fatty liver disease in patients with metabolic syndrome. Adv. Biol. Chem. 4, 129-137. doi: 10.4236/abc.2014.42017
20. Gliozzi, M., Walker, R., Muscoli, S., Vitale, C., Gratteri, S., Carresi, C., et al. (2013). Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. Int. J. Cardiol. 170, 140-145. doi: 10.1016/j.ijcard.2013.08.125
21. Graziano, A. C., Cardile, V., Crasci, L., Caggia, S., Dugo, P., Bonina, F., et al. (2012). Protective effects of an extract from Citrus bergamia against inflammatory injury in interferon-gamma and histamine exposed human keratinocytes. Life Sci. 90, 968-974. doi: 10.1016/j.lfs.2012.04.043
22. Houston, M. C., Fazio, S., Chilton, F. H., Wise, D. E., Jones, K. B., Barringer, T. A., et al. (2009). Nonpharmacologic treatment of dyslipidemia. Prog. Cardiovasc. Dis. 52, 61-94. doi: 10.1016/j.pcad.2009.02.002
23. Kumar, A., Chambers, T. C., Cloud-Heflin, B. A., and Mehta, K. D. (1997). Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation. J. Lipid Res. 38, 2240-2248.
24. Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., et al. (2008). Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am. J. Cardiol. 101, 1689-1693. doi: 10.1016/j.amjcard.2008.02.056
25. Mannarino, M. R., Ministrini, S., and Pirro, M. (2014). Nutraceuticals for the treatment of hypercholesterolemia. Eur. J. Int. Med. 25, 592-599. doi: 10.1016/j.ejim.2014.06.008
26. Miceli, N., Mondello, M. R., Monforte, M. T., Sdrafkakis, V., Dugo, P., Crupi, M. L., et al. (2007). Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet. J. Agric. Food Chem. 55, 10671-10677. doi: 10.1021/jf071772i
27. Mikhailidis, D. P., Elisaf, M., Rizzo, M., Berneis, K., Griffin, B., Zambon, A., et al. (2011a). "European panel on low density lipoprotein (LDL) subclasses:" a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr. Vasc. Pharmacol. 9, 533-571. doi: 10.2174/157016111796642698
28. Mikhailidis, D. P., Elisaf, M., Rizzo, M., Berneis, K., Griffin, B., Zambon, A., et al. (2011b). "European panel on low density lipoprotein (LDL) subclasses:" a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr. Vasc. Pharmacol. 9, 531-532. doi: 10.2174/157016111796642661
29. Mollace, V., Ragusa, S., Sacco, I., Muscoli, C., Sculco, F., Visalli, V., et al. (2008). The protective effect of bergamot oil extract on lecitine-like oxyLDL receptor-1 expression in balloon injury-related neointima formation. J. Cardiovasc. Pharmacol. Ther. 13, 120-129. doi: 10.1177/1074248407313821
30. Mollace, V., Sacco, I., Janda, E., Malara, C., Ventrice, D., Colica, C., et al. (2011). Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia 82, 309-316. doi: 10.1016/j.fitote.2010.10.014
31. Naderi, G. A., Asgary, S., Sarraf-Zadegan, N., and Shirvany, H. (2003). Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol. Cell. Biochem. 246, 193-196. doi: 10.1023/A:1023483223842
32. Nikolic, D., Katsiki, N., Montalto, G., Isenovic, E. R., Mikhailidis, D. P., and Rizzo, M. (2013). Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients 5, 928-948. doi: 10.3390/nu5030928
33. Nogata, Y., Sakamoto, K., Shiratsuchi, H., Ishii, T., Yano, M., and Ohta, H. (2006). Flavonoid composition of fruit tissues of citrus species. Biosci. Biotechnol. Biochem. 70, 178-192. doi: 10.1271/bbb.70.178
34. Pandey, K. B., and Rizvi, S. I. (2009). Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med. Cell Longev. 2, 270-278. doi: 10.4161/oxim.2.5.9498
35. Patti, A. M., Katsiki, N., Nikolic, D., Al-Rasadi, K., and Rizzo, M. (2015). Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan. Angiology 66, 416-421. doi: 10.1177/0003319714542999
36. Quesada, H., del Bas, J. M., Pajuelo, D., Diaz, S., Fernandez-Larrea, J., Pinent, M., et al. (2009). Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. Int. J. Obes (Lond.) 33, 1007-1012. doi: 10.1038/ijo.2009.136
37. Reddy, S., Yang, W., Taylor, D. G., Shen, X., Oxender, D., Kust, G., et al. (1999). Mitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4. J. Biol. Chem. 274, 33050-33056. doi: 10.1074/jbc.274.46.33050
38. Risitano, R., Curro, M., Cirmi, S., Ferlazzo, N., Campiglia, P., Caccamo, D., et al. (2014). Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-kappaB inhibition in THP-1 monocytes. PLoS ONE 9:e107431. doi: 10.1371/journal.pone.0107431
39. Rizzo, M., and Berneis, K. (2006a). Effect of statins on low-density lipoprotein size: a new role in cardiovascular prevention? South Med. J. 99, 1015-1016. doi: 10.1097/01.smj.0000235471.56184.77
40. Rizzo, M., and Berneis, K. (2006b). The clinical relevance of low-density-lipoproteins size modulation by statins. Cardiovasc. Drugs. Ther. 20, 205-217. doi: 10.1007/s10557-006-8283-x
41. Rizzo, M., Berneis, K., Koulouris, S., Pastromas, S., Rini, G. B., Sakellariou, D., et al. (2010). Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes? Int. J. Clin. Pract. 64, 1632-1642. doi: 10.1111/j.1742-1241.2010.02378.x
42. Rizzo, M., Giglio, R. V., Nikolic, D., Patti, A. M., Campanella, C., Cocchi, M., et al. (2014). Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study. Angiology 65, 538-542. doi: 10.1177/0003319713493126
43. Rizzo, M., Rini, G. B., and Berneis, K. (2007). Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients. Adv. Ther. 24, 575-582. doi: 10.1007/BF02848780
44. Sakurada, T., Mizoguchi, H., Kuwahata, H., Katsuyama, S., Komatsu, T., Morrone, L. A., et al. (2011). Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism. Pharmacol. Biochem. Behav. 97, 436-443. doi: 10.1016/j.pbb.2010.09.020
45. Salamone, F., Galvano, F., Cappello, F., Mangiameli, A., Barbagallo, I., and Li Volti, G. (2012). Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl. Res. 159, 477-486. doi: 10.1016/j.trsl.2011.12.003
46. Scichilone, N., Rizzo, M., Benfante, A., Catania, R., Giglio, R. V., Nikolic, D., et al. (2013). Serum low density lipoprotein subclasses in asthma. Respir. Med. 107, 1866-1872. doi: 10.1016/j.rmed.2013.09.001
47. Srisawasdi, P., Vanavanan, S., Rochanawutanon, M., Pornsuriyasak, P., Tantrakul, V., Kruthkul, K., et al. (2013). Heterogeneous properties of intermediate-and low-density lipoprotein subpopulations. Clin. Biochem. 46, 1509-1515. doi: 10.1016/j.clinbiochem.2013.06.021
48. Stampfer, M. J., Krauss, R. M., Ma, J., Blanche, P. J., Holl, L. G., Sacks, F. M., et al. (1996). A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276, 882-888. doi: 10.1001/jama.276.11.882
49. Trombetta, D., Cimino, F., Cristani, M., Mandalari, G., Saija, A., Ginestra, G., et al. (2010). In vitro protective effects of two extracts from bergamot peels on human endothelial cells exposed to tumor necrosis factor-alpha (TNF-alpha). J. Agric. Food Chem. 58, 8430-8436. doi: 10.1021/jf1008605
50. Tsutsumi, R., Yoshida, T., Nii, Y., Okahisa, N., Iwata, S., Tsukayama, M., et al. (2014). Sudachitin, a polymethoxylated flavone, improves glucose and lipid metabolism by increasing mitochondrial biogenesis in skeletal muscle. Nutr. Metab. (Lond.) 11:32. doi: 10.1186/1743-7075-11-32
51. Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Blanche, P. J., Holl, L. G., et al. (2003). Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler. Thromb. Vasc. Biol. 23, 314-321. doi: 10.1161/01.ATV.0000053385.64132.2D
52. Yu, J., Wang, L., Walzem, R. L., Miller, E. G., Pike, L. M., and Patil, B. S. (2005). Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J. Agric. Food Chem. 53, 2009-2014. doi: 10.1021/jf0484632